Trial Outcomes & Findings for Pilot Study to Improve Therapeutic Outcomes for Dysphagia After Radiation Therapy (NCT NCT02564887)
NCT ID: NCT02564887
Last Updated: 2020-03-23
Results Overview
Change in tongue strength from baseline measurements; 2nd measurement collected post treatment (approximately 8 weeks from baseline)
TERMINATED
NA
26 participants
8 weeks
2020-03-23
Participant Flow
Participant milestones
| Measure |
Traditional Therapy Only
Standard of care therapy for qualifying population (with opportunity to "crossover" and be assigned to the IOPI device if so desired after initial 8 week standard of care therapy completion.
Iowa Oral Performance Instrument: the IOPI device is being used to increase tongue strength and endurance
|
Traditional Therapy With IOPI
Standard of care therapy plus the addition of the IOPI instrument
Iowa Oral Performance Instrument: the IOPI device is being used to increase tongue strength and endurance
|
|---|---|---|
|
Overall Study
STARTED
|
16
|
10
|
|
Overall Study
COMPLETED
|
10
|
10
|
|
Overall Study
NOT COMPLETED
|
6
|
0
|
Reasons for withdrawal
| Measure |
Traditional Therapy Only
Standard of care therapy for qualifying population (with opportunity to "crossover" and be assigned to the IOPI device if so desired after initial 8 week standard of care therapy completion.
Iowa Oral Performance Instrument: the IOPI device is being used to increase tongue strength and endurance
|
Traditional Therapy With IOPI
Standard of care therapy plus the addition of the IOPI instrument
Iowa Oral Performance Instrument: the IOPI device is being used to increase tongue strength and endurance
|
|---|---|---|
|
Overall Study
Lost to Follow-up
|
6
|
0
|
Baseline Characteristics
Pilot Study to Improve Therapeutic Outcomes for Dysphagia After Radiation Therapy
Baseline characteristics by cohort
| Measure |
Traditional Therapy Only
n=10 Participants
Standard of care therapy for qualifying population (with opportunity to "crossover" and be assigned to the IOPI device if so desired after initial 8 week standard of care therapy completion.
Iowa Oral Performance Instrument: the IOPI device is being used to increase tongue strength and endurance
|
Traditional Therapy With IOPI
n=10 Participants
Standard of care therapy plus the addition of the IOPI instrument
Iowa Oral Performance Instrument: the IOPI device is being used to increase tongue strength and endurance
|
Total
n=20 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
8 Participants
n=5 Participants
|
7 Participants
n=7 Participants
|
15 Participants
n=5 Participants
|
|
Age, Categorical
>=65 years
|
2 Participants
n=5 Participants
|
3 Participants
n=7 Participants
|
5 Participants
n=5 Participants
|
|
Age, Continuous
|
62.7 years
n=5 Participants
|
62 years
n=7 Participants
|
62 years
n=5 Participants
|
|
Sex: Female, Male
Female
|
0 Participants
n=5 Participants
|
3 Participants
n=7 Participants
|
3 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
10 Participants
n=5 Participants
|
7 Participants
n=7 Participants
|
17 Participants
n=5 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Asian
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Black or African American
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
White
|
10 Participants
n=5 Participants
|
10 Participants
n=7 Participants
|
20 Participants
n=5 Participants
|
|
Race (NIH/OMB)
More than one race
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Region of Enrollment
United States
|
10 participants
n=5 Participants
|
10 participants
n=7 Participants
|
26 participants
n=5 Participants
|
|
Tongue Strength (kPa)
|
44.5 kPa
n=5 Participants
|
41.4 kPa
n=7 Participants
|
42.95 kPa
n=5 Participants
|
PRIMARY outcome
Timeframe: 8 weeksChange in tongue strength from baseline measurements; 2nd measurement collected post treatment (approximately 8 weeks from baseline)
Outcome measures
| Measure |
Traditional Therapy Only
n=10 Participants
Standard of care therapy for qualifying population (with opportunity to "crossover" and be assigned to the IOPI device if so desired after initial 8 week standard of care therapy completion.
Iowa Oral Performance Instrument: the IOPI device is being used to increase tongue strength and endurance
Tongue strength was measured pre- and post-treatment with the Iowa Oral performance Instrument which measures linguapalatal pressure/force generation in kilopascals of pressure.
|
Traditional Therapy With IOPI
n=10 Participants
Standard of care therapy plus the addition of the IOPI instrument
Iowa Oral Performance Instrument: the IOPI device is being used to increase tongue strength and endurance
Tongue strength was measured pre- and post-treatment with the Iowa Oral performance Instrument which measures linguapalatal pressure/force generation in kilopascals of pressure.
|
|---|---|---|
|
Tongue Pressure Generation (i.e. Tongue Strength) in Kilopascals (kPa) Using the IOPI Device
|
7.9 kPa
Interval 0.0 to 13.0
|
5.1 kPa
Interval -4.0 to 23.0
|
SECONDARY outcome
Timeframe: 8 weekPopulation: Not all participants were evaluated using a modified barium swallow test. Reasons that a participant did not perform the MBS, would be safety (the clinician did not feel that is was safe for the participant to undergo the MBS) or not indicated (an MBS was not clinically indicated at that time). Only completed MBS tests were evaluated.
Penetration-aspiration scale score of the modified barium swallow (MBS) data for small, thin liquids Scores are determined primarily by the depth to which material passes in the airway and by whether or not material entering the airway is expelled. Minimum 1 Maximum 8 Lower is better The score being evaluated is an absolute score at the time of collection and not the change over time.
Outcome measures
| Measure |
Traditional Therapy Only
n=4 Participants
Standard of care therapy for qualifying population (with opportunity to "crossover" and be assigned to the IOPI device if so desired after initial 8 week standard of care therapy completion.
Iowa Oral Performance Instrument: the IOPI device is being used to increase tongue strength and endurance
Tongue strength was measured pre- and post-treatment with the Iowa Oral performance Instrument which measures linguapalatal pressure/force generation in kilopascals of pressure.
|
Traditional Therapy With IOPI
n=9 Participants
Standard of care therapy plus the addition of the IOPI instrument
Iowa Oral Performance Instrument: the IOPI device is being used to increase tongue strength and endurance
Tongue strength was measured pre- and post-treatment with the Iowa Oral performance Instrument which measures linguapalatal pressure/force generation in kilopascals of pressure.
|
|---|---|---|
|
Airway Protection During Swallowing
|
4.875 score on a scale
Interval 2.0 to 6.5
|
4.56 score on a scale
Interval 1.0 to 8.0
|
SECONDARY outcome
Timeframe: 8 weekPopulation: While the Traditional Therapy Only and the Traditional Therapy with IOPI groups each contain n=10 participants, only 6 swallowing evaluations underwent evaluation for this particular measure. Detailed swallowing evaluations were only performed in participants who were felt to be "safe" to undergo the evaluations.
The change in pharyngeal retention measured using the normalized residue ratio scale (NRR) is being assessed. The NRR quantifies the amount of residue remaining in the valleculae and pyriform sinuses after a swallow as a ratio of the total area of each of these two pharyngeal spaces. Value represents the area of space that is occupied by barium at the end of a swallow. The change from baseline to 8 weeks is documented. A positive change (+) is worsening of symptoms. A negative change (-) is bettering of symptoms.
Outcome measures
| Measure |
Traditional Therapy Only
n=6 Participants
Standard of care therapy for qualifying population (with opportunity to "crossover" and be assigned to the IOPI device if so desired after initial 8 week standard of care therapy completion.
Iowa Oral Performance Instrument: the IOPI device is being used to increase tongue strength and endurance
Tongue strength was measured pre- and post-treatment with the Iowa Oral performance Instrument which measures linguapalatal pressure/force generation in kilopascals of pressure.
|
Traditional Therapy With IOPI
n=6 Participants
Standard of care therapy plus the addition of the IOPI instrument
Iowa Oral Performance Instrument: the IOPI device is being used to increase tongue strength and endurance
Tongue strength was measured pre- and post-treatment with the Iowa Oral performance Instrument which measures linguapalatal pressure/force generation in kilopascals of pressure.
|
|---|---|---|
|
Change Over Time of Pharyngeal Residue After Swallowing
Pyriform
|
.0160 units on a scale
Interval -0.0013 to 0.0587
|
.0105 units on a scale
Interval -0.0001 to 0.031
|
|
Change Over Time of Pharyngeal Residue After Swallowing
Vallecula
|
-.0268 units on a scale
Interval -0.0431 to 0.0131
|
-.0589 units on a scale
Interval -0.2007 to 0.03
|
SECONDARY outcome
Timeframe: 8 weekPatient perceived outcome measure related to their view of their swallowing problem/difficulties at that point in time. Eating Assessment Tool (EAT-10). Minimum score 0 Maximum score 40 Higher score is worse Number reported is final overall score
Outcome measures
| Measure |
Traditional Therapy Only
n=10 Participants
Standard of care therapy for qualifying population (with opportunity to "crossover" and be assigned to the IOPI device if so desired after initial 8 week standard of care therapy completion.
Iowa Oral Performance Instrument: the IOPI device is being used to increase tongue strength and endurance
Tongue strength was measured pre- and post-treatment with the Iowa Oral performance Instrument which measures linguapalatal pressure/force generation in kilopascals of pressure.
|
Traditional Therapy With IOPI
n=10 Participants
Standard of care therapy plus the addition of the IOPI instrument
Iowa Oral Performance Instrument: the IOPI device is being used to increase tongue strength and endurance
Tongue strength was measured pre- and post-treatment with the Iowa Oral performance Instrument which measures linguapalatal pressure/force generation in kilopascals of pressure.
|
|---|---|---|
|
Swallowing Impairment-Self Report
|
14.4 score on scale
Interval 3.0 to 24.0
|
15.5 score on scale
Interval 3.0 to 34.0
|
SECONDARY outcome
Timeframe: 8 weekvisual analog scale related to patient perceived swallowing impairment at that point in time. Minimum - 0 Maximum - 100 Higher is worse Score reported is the overall score at that time and not a change from baseline.
Outcome measures
| Measure |
Traditional Therapy Only
n=10 Participants
Standard of care therapy for qualifying population (with opportunity to "crossover" and be assigned to the IOPI device if so desired after initial 8 week standard of care therapy completion.
Iowa Oral Performance Instrument: the IOPI device is being used to increase tongue strength and endurance
Tongue strength was measured pre- and post-treatment with the Iowa Oral performance Instrument which measures linguapalatal pressure/force generation in kilopascals of pressure.
|
Traditional Therapy With IOPI
n=10 Participants
Standard of care therapy plus the addition of the IOPI instrument
Iowa Oral Performance Instrument: the IOPI device is being used to increase tongue strength and endurance
Tongue strength was measured pre- and post-treatment with the Iowa Oral performance Instrument which measures linguapalatal pressure/force generation in kilopascals of pressure.
|
|---|---|---|
|
Swallowing Impairment
|
31.1 score on a scale
Interval 5.0 to 60.0
|
30.5 score on a scale
Interval 0.0 to 80.0
|
SECONDARY outcome
Timeframe: 8 weekfunctional oral intake scale (FOIS) The Functional Oral Intake Scale is an ordinal scale that is used to assess the current status and meaningful change in the oral intake. Minimum - 1 Maximum - 7 Higher is better Score reported is the overall score at that point in time and not a change from baseline.
Outcome measures
| Measure |
Traditional Therapy Only
n=10 Participants
Standard of care therapy for qualifying population (with opportunity to "crossover" and be assigned to the IOPI device if so desired after initial 8 week standard of care therapy completion.
Iowa Oral Performance Instrument: the IOPI device is being used to increase tongue strength and endurance
Tongue strength was measured pre- and post-treatment with the Iowa Oral performance Instrument which measures linguapalatal pressure/force generation in kilopascals of pressure.
|
Traditional Therapy With IOPI
n=10 Participants
Standard of care therapy plus the addition of the IOPI instrument
Iowa Oral Performance Instrument: the IOPI device is being used to increase tongue strength and endurance
Tongue strength was measured pre- and post-treatment with the Iowa Oral performance Instrument which measures linguapalatal pressure/force generation in kilopascals of pressure.
|
|---|---|---|
|
Swallowing Impairment-Objective
|
5.5 score on a scale
Interval 2.0 to 7.0
|
5.2 score on a scale
Interval 2.0 to 7.0
|
Adverse Events
Traditional Therapy Only
Traditional Therapy With IOPI
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Christine Harrison, Clinical Research Coordinator
University of Pittsburgh
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place